Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WRSS1 Shigella vaccine in Bangladeshi toddlers
NCT02934178Phase 1Completed
- Sponsor
- PATH
- Start
- Feb 2017
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of shigella sonnei strain wrss1 vaccine in shigellosis and diarrhea, sponsored by PATH. Started Feb 2017; status: completed.
02
Drugs
shigella sonnei strain wrss1 vaccine
03
Conditions
shigellosisdiarrhea
Beyond the preview
Go deeper on NCT02934178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02934178.